An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetic Autonomic Neuropathy

In brief

The focus of this project is cardiovascular diabetic autonomic neuropathy (DAN). DAN affects the nerves that control heart rate and blood flow to the heart in people with diabetes. DAN may cause problems with the rhythm of the heartbeat or decrease blood flow to the heart. Three medications will be tested for their effectiveness in DAN.

Key facts

Study ID

NCT00116207

Run by

University of Michigan

People needed

44

Starts

2000-01-01

Expected to finish

2009-12-01

Last updated by the study team

2016-07-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 1 diabetes
• A1C <9%
• Mild neuropathy
• Mild retinopathy
• Mild nephropathy

You may not qualify if…

• History of drug or alcohol dependence, heart disease, viral illness, liver disease, advanced kidney disease
• Pregnant or nursing
• Severely overweight

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.